Lambros Stamatakis MD

Author

Lambros Stamatakis, MD, Director, Urologic Oncology

Lambros Stamatakis, MD, is the director of Urologic Oncology at MedStar Washington Hospital Center, and specializes in malignant diseases of the urologic system.

View Doctor Profile

Immunotherapy: The future course of bladder cancer care

by Lambros Stamatakis, MD, Director, Urologic Oncology
December 14, 2017

In the 1990s, the Food and Drug Administration (FDA) approved a treatment for bladder cancer called Bacillus Calmette-Guerin therapy, or…

Treating bladder cancer: What patients need to know

by Lambros Stamatakis, MD, Director, Urologic Oncology
November 14, 2017

While bladder cancer doesn’t get as much press as colon or lung cancer, it’s the fourth-most common type of cancer…

What to do when prostate cancer biopsy/PSA test results conflict

by Ross Krasnow, MD, MPH, Urologic Oncologist, Lambros Stamatakis, MD, Director, Urologic Oncology
September 28, 2017

Prostate cancer can be challenging to detect. Our screening and diagnostic tools—prostate-specific antigen (PSA) testing and transrectal ultrasound-guided (TRUS) prostate…

Can an advanced MRI improve prostate cancer screening?

by Keith Kowalczyk, MD, Urologist and Robotic Surgeon, Lambros Stamatakis, MD, Director, Urologic Oncology
January 27, 2017

Prostate cancer is notoriously tricky to detect. It often doesn’t cause symptoms until it’s advanced, and there are no routine…